Friday, July 31, 2026

Bukwang Pharmaceutical builds turnaround momentum, eyes Parkinson’s drug progress in second half

Bukwang Pharmaceutical is advancing its Parkinson’s treatment CP-012 into a global Phase 2 trial while enhancing RNA technology and manufacturing.

South Korea’s Central Bank Turns More Optimistic: 2.0% Growth, Sixth Straight Rate Hold—Is the Chip Cycle Doing the Heavy Lifting?

Bank of Korea raises 2023 growth forecast to 2.0% due to strong semiconductors and consumption, while maintaining interest rates at 2.50%.

North Korea Marks 72nd Victory Day with Parade, Kim Jong Un Notably Absent

North Korea celebrated Victory Day with a parade, veteran reunions, and performances, emphasizing its historical triumphs and military spirit.

Tag: P-CAB

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

HK inno.N’s New Drug K-CAB Applies for U.S. FDA Approval: How Innovative Is the P-CAB Therapy?

HK inno.N's K-Cap for GERD has entered the U.S. approval process, showing superior results in clinical trials over existing treatments.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.